Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: A Gynecologic Oncology Group study()

OBJECTIVE(S). The Gynecologic Oncology Group (GOG) examined the association between ERBB2 amplification and clinical covariates, tumor response, disease status post-chemotherapy, progression-free survival (PFS), and overall survival (OS) in epithelial ovarian cancer (EOC). METHODS. Women with subopt...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Gynecol Oncol
Asıl Yazarlar: Farley, John, Fuchiuji, Sartoru, Darcy, Kathleen M., Tian, Chunqiao, Hoskins, William J., McGuire, William P., Hanjani, Parviz, Warshal, David, Greer, Benjamin E., Belinson, Jerome, Birrer, Michael J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944288/
https://ncbi.nlm.nih.gov/pubmed/19272639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2009.02.009
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller